Arab Hany H, Al-Shorbagy Muhammad Y, Abdallah Dalaal M, Nassar Noha N
Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
PLoS One. 2014 May 15;9(5):e97193. doi: 10.1371/journal.pone.0097193. eCollection 2014.
Accumulating evidence has indicated the implication of angiotensin II in the pathogenesis of inflammatory bowel diseases (IBD) via its proinflammatory features. Telmisartan (TLM) is an angiotensin II receptor antagonist with marked anti-inflammatory and antioxidant actions that mediated its cardio-, reno- and hepatoprotective actions. However, its impact on IBD has not been previously explored. Thus, we aimed to investigate the potential alleviating effects of TLM in tri-nitrobenezene sulphonic acid (TNBS)-induced colitis in rats. Pretreatment with TLM (10 mg/kg p.o.) attenuated the severity of colitis as evidenced by decrease of disease activity index (DAI), colon weight/length ratio, macroscopic damage, histopathological findings and leukocyte migration. TLM suppressed the inflammatory response via attenuation of tumor necrosis factor-α (TNF-α), prostaglandin E2 (PGE2) and myeloperoxidase (MPO) activity as a marker of neutrophil infiltration besides restoration of interleukin-10 (IL-10). TLM also suppressed mRNA and protein expression of nuclear factor kappa B (NF-κB) p65 and mRNA of cyclo-oxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) proinflammatory genes with concomitant upregulation of PPAR-γ. The alleviation of TLM to colon injury was also associated with inhibition of oxidative stress as evidenced by suppression of lipid peroxides and nitric oxide (NO) besides boosting glutathione (GSH), total anti-oxidant capacity (TAC) and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx). With respect to apoptosis, TLM downregulated the increased mRNA, protein expression and activity of caspase-3. It also suppressed the elevation of cytochrome c and Bax mRNA besides the upregulation of Bcl-2. Together, these findings highlight evidences for the beneficial effects of TLM in IBD which are mediated through modulation of colonic inflammation, oxidative stress and apoptosis.
越来越多的证据表明,血管紧张素II通过其促炎特性参与了炎症性肠病(IBD)的发病机制。替米沙坦(TLM)是一种血管紧张素II受体拮抗剂,具有显著的抗炎和抗氧化作用,介导了其心脏、肾脏和肝脏保护作用。然而,其对IBD的影响此前尚未被研究过。因此,我们旨在研究TLM对三硝基苯磺酸(TNBS)诱导的大鼠结肠炎的潜在缓解作用。用TLM(10mg/kg口服)预处理可减轻结肠炎的严重程度,疾病活动指数(DAI)降低、结肠重量/长度比、宏观损伤、组织病理学结果和白细胞迁移减少均证明了这一点。TLM通过减弱肿瘤坏死因子-α(TNF-α)、前列腺素E2(PGE2)和髓过氧化物酶(MPO)活性(作为中性粒细胞浸润的标志物)以及恢复白细胞介素-10(IL-10)来抑制炎症反应。TLM还抑制了核因子κB(NF-κB)p65的mRNA和蛋白表达以及环氧化酶-2(COX-2)和诱导型一氧化氮合酶(iNOS)促炎基因的mRNA,同时上调了过氧化物酶体增殖物激活受体-γ(PPAR-γ)。TLM对结肠损伤的缓解还与氧化应激的抑制有关,脂质过氧化物和一氧化氮(NO)的抑制以及谷胱甘肽(GSH)、总抗氧化能力(TAC)以及超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)活性的增强均证明了这一点。关于细胞凋亡,TLM下调了半胱天冬酶-3增加的mRNA、蛋白表达和活性。它还抑制了细胞色素c和Bax mRNA的升高,同时上调了Bcl-2。总之,这些发现突出了TLM在IBD中有益作用的证据,这些作用是通过调节结肠炎症、氧化应激和细胞凋亡介导的。